The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of a randomized controlled, open-label, multi-center phase II study of camrelizumab combined with chemotherapy followed by concurrent chemoradiotherapy and camrelizumab consolidation therapy versus standard chemoradiotherapy as first-line treatment for limited-disease small cell lung cancer.
 
Xu Yaping
No Relationships to Disclose
 
Jian Ni
No Relationships to Disclose
 
Shengxiang Ren
No Relationships to Disclose
 
Xiaoling Xu
No Relationships to Disclose
 
Min Hu
No Relationships to Disclose
 
Qinghua Xu
No Relationships to Disclose
 
Yun Chen
No Relationships to Disclose
 
Yaoyao Zhu
No Relationships to Disclose